Chordia Therapeutics Inc

Japanese biopharma companies were once industry leaders. In the 1980s, Japanese companies introduced 29% of all new chemical entities approved by the US Food and Drug Administration. The picture is qu

Citeline was delighted to be able to recognize and celebrate excellence across the Japanese pharma, biotech and clinical research industries at the 2nd Citeline Pharma Intelligence Awards Japan, held

Citeline was delighted to be able to recognize and celebrate excellence across the Japanese pharma, biotech and clinical research industries at the 2nd Citeline Pharma Intelligence Awards Japan, held

Japan’s largest R&D hub for bioventures and pharma startups, Shonan Health Innovation Park (Shonan iPark), has been in active talks with Korean bioventures and government groups over the formation of